Global Peptide CDMO Supply, Demand and Key Producers, 2023-2029

Global Peptide CDMO Supply, Demand and Key Producers, 2023-2029

The global Peptide CDMO market size is expected to reach $ 8327.1 million by 2029, rising at a market growth of 14.3% CAGR during the forecast period (2023-2029).

Global key peptide CDMO producers include Bachem, PolyPeptide, CordenPharma, and others. The top five manufacturers together account for 40% of the market share, with the largest manufacturer being Bachem with 17%. At the sales level, North America is the largest sales market with a market share of over 50%, followed by Europe and China with 33% and 9% respectively. In terms of product categories, it is divided into APIs and intermediates and FDF, with the former holding the major market share of 67%. In terms of application, commercial is the top application area with a market share of 76%, followed by academic research institutions.

Peptides are synthesized by coupling the carboxyl group of one amino acid to the amino group of another amino acid molecule. Due to the possibility of unintended reactions, protecting groups are common necessary. Chemical peptide synthesis most commonly starts at the carboxyl end of the peptide, and thus progress toward the amino-terminus. This is the opposite direction of protein biosynthesis.

A contract development and manufacturing company (CDMO) is a company within the pharmaceutical industry that provides drug development and manufacturing services. Pharmaceutical companies partner with CDMOs as a way to outsource drug development and drug manufacturing.

CDMO peptides production via contract peptide manufacturing is to optimize process development and achieve highly efficient conversion at every amino acid coupling to produce a high-purity crude synthetic custom peptide and minimize the demands on downstream processing.

This report studies the global Peptide CDMO demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Peptide CDMO, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Peptide CDMO that contribute to its increasing demand across many markets.

Highlights and key features of the study

Global Peptide CDMO total market, 2018-2029, (USD Million)

Global Peptide CDMO total market by region & country, CAGR, 2018-2029, (USD Million)

U.S. VS China: Peptide CDMO total market, key domestic companies and share, (USD Million)

Global Peptide CDMO revenue by player and market share 2018-2023, (USD Million)

Global Peptide CDMO total market by Type, CAGR, 2018-2029, (USD Million)

Global Peptide CDMO total market by Application, CAGR, 2018-2029, (USD Million)

This reports profiles major players in the global Peptide CDMO market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Bachem, PolyPeptide, CordenPharma, AmbioPharm, USV Peptides, Thermofischer, Bio Basic, JPT and Genscript, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Peptide CDMO market

Detailed Segmentation:

Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Peptide CDMO Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global Peptide CDMO Market, Segmentation by Type
APIs and Intermediates
FDF

Global Peptide CDMO Market, Segmentation by Application
Commercial
Academic Research
Other

Companies Profiled:
Bachem
PolyPeptide
CordenPharma
AmbioPharm
USV Peptides
Thermofischer
Bio Basic
JPT
Genscript
Xinbang Pharma
ScinoPharm
SN Biopharm
CBL
Piramal Pharma
CPC Scientific

Key Questions Answered

1. How big is the global Peptide CDMO market?

2. What is the demand of the global Peptide CDMO market?

3. What is the year over year growth of the global Peptide CDMO market?

4. What is the total value of the global Peptide CDMO market?

5. Who are the major players in the global Peptide CDMO market?

6. What are the growth factors driving the market demand?